Over the past year, RGAX’s Future of Healthcare Roundtable Series explored the good, the bad, and the unexpected activities that have occurred across life insurance, insurtech, and healthcare so far during the pandemic and their impact on the future of these spaces. We tapped into insurtech, healthtech, behavior science, venture capital, and healthcare technologist experts to discuss everything from eldercare, digitalization, and investments to innovation, insurance sales, and behavioral science.
Dr. James Somauroo, the founder of SomX and well-known healthtech visionary, joined us as resident moderator to facilitate the dynamic discussions while RGAX’s Kate Lyons (Crick), RGAX’s Market Development and Commercial Director for the U.K, was “onsite” to extract and assess key insights and trends shared. Between the two, we captured a wealth of information that you can access firsthand in the roundup below.
Worldwide, the number of people over 60 has more than doubled in the last three decades. As life expectancies continue to increase, the healthcare needs of the population change and so do the challenges that carriers, healthcare providers, and those who provide daily care for the elderly experience. Insurtech and healthtech innovations are helping to ease the strain for all involved.
In this session, James was joined by healthcare technologists, Amer Fasihi and Max Parmentier, as well as Kate Lyons, to explore the growing role of technology in caring for the elderly. Dive into the challenges and solutions discussed in these articles:
Topic: Digitalization & Digitization in Healthcare
Undoubtedly, the digitalization of healthcare has the power to improve the health and well-being of people worldwide. However, reaching that goal comes with challenges. In this content-packed roundtable session, James was joined by Stephen Bourke, co-founder of Echo, an online pharmacy, and Emmanuel Djengue, Innovations Director at RGAX.
Although both digitalization and digitization are important to achieving digital transformation goals, these experts distinguished between them when discussing the obstacles to overcome. The conversation is not one to miss. Check out episodes 1 and 2 here:
Topic: COVID-19 and the Insurtech Ecosystem
To get a true understanding of how the pandemic has impacted the insurtech ecosystem, we invited three experts to join our discussion, each with a different role and perspective:
André Dreyer is Vice President of Ventures and Acquisitions at RGAX. Based in South Africa, Andre is focused on partnering with insurtech startups around the world.
Josh Hart is an insurtech entrepreneur and co-founder of YuLife, a company that seeks to “transform traditional insurance and employee benefits into life-enhancing experiences every employee will value and use.” YuLife has a global reach, but Josh and his company are based in London.
Tune into the conversation to hear the frank – and at times unexpected – insights into how the pandemic has impacted the work they do.
Topic: How COVID-19 Impacted Life Insurance Sales
Finally, there has been much discussion around the impact of COVID-19 on life insurance sales. Life insurance sales have generally increased during the pandemic, but not always in predictable ways.
To dig a bit deeper into the reasons behind the sales trends, we invited two behavioral science experts to provide their perspectives: Emma Jones, Executive Director, Underwriting Innovation and Strategic Development at RGAX EMEA, and Matt Battersby, Chief Behavioral Scientist at RGA. Their insights can help carriers and agents better reach underserved populations and navigate future events.
Got a topic you’d like to see discussed?
This wraps up our current Roundtable series on the Future of Healthcare. RGAX would like to thank all the experts who so graciously contributed their time and thoughts to the discussion. A special thanks to Dr. James Somauroo for hosting these roundtables and keeping the discussions on track.